• <b id="qfd60"></b>

    <listing id="qfd60"><source id="qfd60"></source></listing>

      1. <listing id="qfd60"></listing>
          <b id="qfd60"></b>

            <b id="qfd60"></b>

            當前位置 : Millipore >>> Millipore/AB5112 | Anti-Parkin Antibody, a.a. 305-323/AB5112/50 µL
            Millipore/AB5112 | Anti-Parkin Antibody, a.a. 305-323/AB5112/50 µL
            • Millipore/AB5112 | Anti-Parkin Antibody, a.a. 305-323/AB5112/50 µL

            Millipore/AB5112 | Anti-Parkin Antibody, a.a. 305-323/AB5112/50 µL

            價格: ¥4560.00 市場價: 7600.00

            貨號: AB5112
            品牌: Millipore
            規格
            數量
            庫存(0)
            特別 提示
            代購產品:無質量問題不接受退換貨,下單前請仔細核對信息。
            下單后請及時聯系客服核對商品價格,訂單生效后再付款。
            資深產品顧問
            咨詢顧問

            全國免費服務熱線

            4000-520-616


            • 自營商城 一站式服務
            • 廠家直采 剔除溢價
            • 品質甄選 正品保證
            • 嚴控流程 只做188精品
            • 極速物流 如約送貨
            • 詳情
            • 使用說明
            • 常見問題
              • Description
                CatalogueNumberAB5112
                BrandFamilyChemicon®
                TradeName
                • Chemicon
                DescriptionAnti-ParkinAntibody,a.a.305-323
                ProductInformation
                FormatSerum
                PresentationRabbitserum.Lyophilized.Reconstitutewith50μLofsteriledistilledwater.Centrifugetoremoveinsolublematerial.Containsnopreservative.
                StorageandShippingInformation
                StorageConditionsMaintainlyophilizedmaterialatat-20°Cto-70°Cforupto12monthsafterdateofreceipt.Afterreconstitutionmaintainat-20°Cto-70°Cinundilutedaliquotsforupto6months.Avoidrepeatedfreeze/thawcycles.Glycerol(ACSgradeorbetter)canbeadded(1:1)forgreaterstABIlity.
                Applications
                ApplicationDetectParkinusingthisAnti-ParkinAntibody,a.a.305-323validatedforuseinELISA,WB,IH.
                KeyApplications
                • ELISA
                • WesternBlotting
                • Immunohistochemistry
                ApplicationNotesImmunohistochemistry:1:1000-1:2000

                OnesiteELISA

                Westernblot:1:1000-1:2000(recognizesadoubletat44-52kDaonblotsofhumanbrain)

                Theimmunogenpeptideisavailable(cat#AG237)forpre-absorbtioncontrols.

                Optimalworkingdilutionsmustbedeterminedbytheenduser.
                BIOLOGicalInformation
                ImmunogenA19aminoacidpeptide(RILGEEQYNRYQQYGAEEC)correspondingtoaminoacids305-323ofthehumanparkinmolecule.Aninternalpeptidesequencewaschosentoavoidthepossibilityofcrossreactivitywithubiquitin.
                Epitopea.a.305-323
                HostRabbit
                SpecificityParkin.Parkinson"sdiseaseisacommonneurodegenerativediseaseiscausedbyslowdeathofneuronsinthesubstantialnigra,abrainregionthatutilizestheneurotransmitterdopamine.Parkin,arecentlydiscoveredgeneencodingalargeprotein,maybeinvolvedinnormalandabnormalproteindegradationincells.RecentevidenceindicatesthatpointmutationsintheParkingeneappeartoberesponsIBLeforthepathogenesisofsomeformsofParkinson"sdisease.
                SpeciesReactivity
                • Human
                • Rat
                AntibodyTypePolyclonalAntibody
                EntrezGeneNumber
                EntrezGeneSummaryTheprecisefunctionofthisgeneisunknown;however,theencodedproteinisacomponentofamultiproteinE3ubiquitinligasecomplexthatmediatesthetargetingofsubstrateproteinsforproteasomaldegradation.MutationsinthisgeneareknowntocauseParkinsondiseaseandautosomalrecessivejuvenileParkinsondisease.Alternativesplicingofthisgeneproducesmultipletranscriptvariantsencodingdistinctisoforms.Additionalsplicevariantsofthisgenehavebeendescribedbutcurrentlylacktranscriptsupport.
                GeneSymbol
                • PARK2
                • PDJ
                • PRKN
                • LPRS2
                • AR-JP
                • parkin
                • EC6.3.2.-
                UniProtNumber
                UniProtSummaryFUNCTION:SwissProt:O60260#FunctionswithinamultiproteinE3ubiquitinligasecomplex,catalyzingthecovalentattachmentofubiquitinmoietiesontosubstrateproteins.ThesesubstratesincludeSYT11,CCNE1,GPR37,STUB1,a22kDaO-linkedglycosylatedisoformofSNCAIPandSEPT5.Mayplayamoregeneralroleintheubiquitinproteasomalpathwaybyparticipatingintheremovaland/ordetoxificationofabnormallyfoldedordamagedprotein.LossofthisubiquitinligaseactivityappearstobethemechanismunderlyingpathogenesisofPARK2.Mayprotectneuronsagainstalphasynucleintoxicity,proteasomaldysfunction,GPR37accumulation,andkainate-inducedexcitotoxicity.Mayplayaroleincontrollingneurotransmittertraffickingatthepresynapticterminalandincalcium-dependentexocytosis.RegulatescyclinEduringneuronalapoptosis.Mayrepresentatumorsuppressorgene.
                SIZE:465aminoacids;51641Da
                SUBUNIT:FormsanE3ubiquitinligasecomplexwithUBE2L3orUBE2L6.PartofaSCF-likecomplex,consistingofPARK2,CUL1andFBXW7.InteractswithSNCAIP.BindstotheC2AandC2BdomainsofSYT11.InteractsandregulatestheturnoverofSEPT5.Partofacomplex,includingSTUB1,HSP70andGPR37.TheamountofSTUB1inthecomplexincreasesduringERstress.STUB1promotesthedissociationofHSP70fromPARK2andGPR37,thusfacilitatingPARK2-mediatedGPR37ubiquitination.HSP70transientlyassociateswithunfoldedGPR37andinhibitstheE3activityofPARK2,whereas,STUB1enhancestheE3activityofPARK2throughpromotionofdissociationofHSP70fromPARK2-GPR37complexes.InteractswithPSMD4andPACRG.InteractswithLRRK2.InteractswithRANBP2.InteractswithSUMO1butnotSUMO2,whichpromotesnuclearlocalizationandautoubiquitination.
                SUBCELLULARLOCATION:Cytoplasm.Note=Co-localizeswithSTY11inneutrites.Co-localizeswithSNCAIPinbrainstemLewybodies.Nucleus.
                TISSUESPECIFICITY:Highlyexpressedinthebrainincludingthesubstantianigra.Expressedinheart,testisandskeletalmuscle.Expressionisdown-regulatedorabsentintumorbiopsies,andabsentinthebrainofPARK2patients.Overexpressionprotectsdopamineneuronsfromkainate-mediatedapoptosis.
                DOMAIN:SwissProt:O60260Theubiquitin-likedomainbindsthePSMD4subunitof26Sproteasomes.
                PTM:Auto-ubiquitinatesinanE2-dependentmannerleADIngtoitsowndegradation.&S-nitrosylated.TheinhibitionofPARK2ubiquitinE3ligaseactivitybyS-nitrosylationcouldcontributetothedegenerativeprocessinPDbyimpairingtheubiquitinationofPARK2substrates.
                DISEASE:SwissProt:O60260#DefectsinPARK2areacauseofParkinsondisease(PD)[MIM:168600].PDisacomplex,multifactorialdisorderthattypicallymanifestsaftertheageof50years,althoughearly-onsetcases(before50years)areknown.PDgenerallyarisesasasporadicconditionbutisoccasionallyinheritedasasimplemendeliantrait.AlthoughsporadicandfamilialPDareverysimilar,inheritedformsofthediseaseusuallybeginatearlieragesandareassociatedwithatypicalclinicalfeatures.PDischaracterizedbybradykinesia,restingtremor,muscularrigidityandposturalinstability,aswellasbyaclinicallysignificantresponsetotreatmentwithlevodopa.ThepathologyofPDinvolvesthelossofdopaminergicneuronsinthesubstantianigraandthepresenceofLewybodies(intraneuronalaccumulationsofaggregatedproteins),insurvivingneuronsinvariousareasofthebrain.&DefectsinPARK2arethecauseofautosomalrecessiveearlyonsetParkinsondisease2(PARK2)[MIM:600116];alsoknownasearly-onsetparkinsonismwithdiurnalfluctuation(EPDF)orautosomalrecessivejuvenileParkinsondisease(PDJ).PARK2issymptomaticallydifferentinseveralaspectsfromidiopathicParkinsondisease,althoughclassicsymptomssuchasbradykinesia,rigidityandtremorarepresent.AdditionalclinicalfeaturesincludeearlyDOPA-induceddyskinesia,diurnalfluctuationofthesymptoms,sleepbenefit,dystoniaandhyper-reflexia.PARK2isusuallycharacterizedbyonsetbefore40,withameanageatonsetof23.2years.Pathologically,PARK2patientsshowlossofdopaminergicneuronsinthesubstantianigra,similartothatseeninParkinsondisease;however,Lewybodies(intraneuronalaccumulationsofaggregatedproteins)areabsent.&DefectsinPARK2maybeinvolvedinthedevelopmentand/orprogressionofovariancancer.
                SIMILARITY:Contains2IBR-typezincfingers.&Contains2RING-typezincfingers.&Contains1ubiquitin-likedomain.
                MISCELLANEOUS:Theparkinlocus(PRKN),adjacenttothe6qtelomereishyper-recombinableandlieswithinFRA6E,thethirdmostcommonfragilesiteintumortissue.
                PhysicochemicalInformation
                Dimensions
                MaterialsInformation
                MaterialsInformation
              售后保障
              螞蟻淘生物188,秉承螞蟻淘一貫的嚴謹態度,由螞蟻淘公司專業人員負責品控、采購、物流、銷售、售后,保障正品優質。以“快速好省,為科研提供好產品、好價格”為理念,直接鏈接原廠家,從全國各地原制造商嚴格挑選188款科研精品,剔除品牌溢價,188生物新電商,把好的產品帶給科研!? 力求給你最優質的商品。
            • Q:生物188產品正品保障嗎?
              A:生物188質量把控人員具有十年的從業經驗,在業界享有良好的口碑;自營商城,直接從廠家采購, 自己的團隊負責國際物流和清關,中間沒有第三方,所有流程嚴格把控,100%保證正品,假一罰十。

              Q:下單后可以修改訂單嗎?
              A:下單后的商品付款之前可以修改;訂單付款成功,需要聯系我們客服進行修改;客服電話:4000-520-616

              Q:可以開發票嗎?
              A:本網站所售商品都是正規清關,均開具16%正規發票,發票金額含配送費金額,另有說明的除外。

              Q:商品幾天可以發貨?
              A:生物188商品,全部現貨銷售,付款后即可發貨,一般一周內送達!

              Q:如何聯系商家?
              A:有任何問題夠可以電話咨詢我們,全國24小時免費服務熱線:4000-520-616 或聯系我們的在線客服QQ:1570468124

              Q:收到的商品少了/發錯了怎么辦?
              A:同個訂單購買多個商品可能會分為一個以上包裹發出,可能不會同時送達,建議查看訂單詳情是否是 部分發貨狀態;如未收到,可聯系在線客服或者致電4000-520-616。

              Q:退換貨/維修需要多長時間?
              A:一般情況下,退貨處理周期為客戶收到產品一個月內(以快遞公司顯示簽收時間為準),包裝規格、 數量、品種不符,外觀毀損、短缺或缺陷,請在收到貨24小時內申請退換貨;特殊商品以合同條款為準。

            何為188

            極簡而嚴謹,我們僅銷售188款生物醫學科研用品,款款都是爆款;因為少所以聚焦,聚焦甄選每一款產品,聚焦服務每一位客戶!

            關注我們 :

            點擊QQ聯系我們
            生物188微信

            關注188微信公眾號

            獲取最新優惠活動通知
            • 品質甄選,正品保證

            • 自營電商,廠家直采

            • 極簡主義,188精品

          1. <b id="qfd60"></b>

            <listing id="qfd60"><source id="qfd60"></source></listing>

              1. <listing id="qfd60"></listing>
                  <b id="qfd60"></b>

                    <b id="qfd60"></b>

                    欧美疯狂做受xxxx高潮